BMJ  1991;302:269-271 (2 February), doi:10.1136/bmj.302.6771.269

Changes in haemostasis after stopping the combined contraceptive pill: implications for major surgery.

G E Robinson, T Burren, I J Mackie, W Bounds, K Walshe, R Faint, J Guillebaud, S J Machin

Margaret Pyke Centre, London.

OBJECTIVE--To investigate the changes in haemostasis in the three months immediately after stopping the combined contraceptive pill. DESIGN--Prospective randomised study. SETTING--Family planning centre in London. SUBJECTS--24 women aged 35-45 investigated before, during, and after six months' use of combined oral contraceptives containing 30 micrograms ethinyl oestradiol together with the progestogens desogestrel or gestodene. MAIN OUTCOME MEASURES AND RESULTS--Blood samples were taken immediately before and after six months of oral contraceptive use and one, two, four, six, eight, and 12 weeks after the pill had been stopped. During the six months of oral contraceptive use the plasma concentration of factor X and fibrinogen increased and that of antithrombin III decreased. Between two and six weeks after stopping the pill a rebound phenomenon occurred with plasma concentrations of antithrombin III increasing (mean change from baseline at two weeks 0.06 IU/l and at six weeks 0.10 IU/l) and fibrinogen decreasing (0.26 g/l change at two weeks and 0.40 g/l at six weeks). Factor X concentrations fell gradually and the values at eight weeks were not significantly different from those found before the combined pill was started. CONCLUSION--The combined pill should be stopped at least four weeks before major surgery, which carries the risk of postoperative thrombosis, to allow the potentially prothrombotic haemostatic changes that occur during its use to be corrected.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Woods, A., Brull, D.J., Humphries, S.E., Montgomery, H.E. (2000). Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6. Eur Heart J 21: 1574-1583  
  • (1999). Drugs in the peri-operative period: 3 - Hormonal contraceptives and hormone replacement therapy. DTB 37: 78-80 [Abstract] [Full text]  
Access jobs at BMJ Careers
Whats new online at Student BMJ